Enzene Biosciences

Private

PuneHealthcare & Life Scienceshttps://www.enzene.com/

Last Round

Series B

Feb 13, 2026

Total Funding Raised

$36.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Enzene Biosciences is a biotechnology company that provides end-to-end contract development and manufacturing organization (CDMO) services and develops biosimilar products using its proprietary continuous manufacturing platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

continuous biomanufacturingCDMOcontract development and manufacturingCIDMObiologics manufacturingbiosimilarsbiotech manufacturingprocess intensificationclinical supplybiologics developmentdrug manufacturingGMP manufacturingbiotech outsourcingpharma manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enzene Biosciences Comparables

Compare Enzene Biosciences with similar companies based on industry and business-model similarity.

Enzene Biosciences comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Rentschler Biopharma SE	84%
Polpharma Biologics	83%
Evotec	80%

View all Comparables

Enzene Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Feb 13, 2026
Corporate Funding	Dec 26, 2025
VC Round	Jan 30, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Viral Shah

Chief Financial Officer And Head Procurement, CS And Legal

Executive Team

Enzene Biosciences Investors

Notable investors and investment history

Enzene Biosciences investors
Investor	Rounds
F-Prime Capital	VC Round
Eight Roads Ventures	VC Round
F-Prime Capital	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 1, 2026
Operational alignment suggests a close relationship with the Alkem group.
Feb 13, 2026
$2.89M round led by Eight Roads Ventures

View all signals

Enzene Biosciences Filings

Explore SEC and related filing metadata, where available.

Enzene Biosciences filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersPune

Employee Range970

Year Founded2006

Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?